When Dr. Debra Langlois learned last week that federal regulators had delayed the review of Pfizer-BioNTech’s coronavirus vaccine for children under 5, her reaction was just as visceral as any parent’s. “I was like, ‘Are you kidding me?’ Every day my daughter can’t be vaccinated, she’s at risk.”
